Angiotensin II type 1 receptor blockade to control blood pressure in postmenopausal women: Influence of hormone replacement therapy

Kidney International, Supplement

Volumn 62, Issue 82, 2002, Pages S36-S41

  Fernández Vega, Francisco ^{a,b,c,d,e,f,g,h}   Abellán, José ^{a,b,c,d,e,f,g,h}   Vegazo, Onofre ^{a,b,c,d,e,f,g,h}   García de Vinuesa, Soledad ^{a,b,c,d,e,f,g,h}   Rodríguez, José Carlos ^{a,b,c,d,e,f,g,h}   Maceira, Benito ^{a,b,c,d,e,f,g,h}   Sanz de Castro, Saturnino ^{a,b,c,d,e,f,g,h}   Nicolás, Roberto Robles ^{a,b,c,d,e,f,g,h}   Luño, José ^{a,b,c,d,e,f,g,h}  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Health Centre of San Andres   (Spain)

^c ASTRAZENECA   (United Kingdom)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^f HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^g HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^h HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

ARB; Candesartan cilexetil; HRT; Hypertension; Post menopausal women; Renin angiotensin aldosterone system

Indexed keywords

ANGIOTENSIN RECEPTOR; CANDESARTAN HEXETIL; HORMONE; HYDROCHLOROTHIAZIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; BIPHENYL DERIVATIVE; DIURETIC AGENT; TETRAZOLE DERIVATIVE;

ADULT; AGE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MENSTRUATION; MULTIVARIATE ANALYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEPTOR BLOCKING; STATISTICAL SIGNIFICANCE; ARTICLE; BLOOD PRESSURE; DRUG COMBINATION; ESTROGEN THERAPY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; SPAIN; TIME; TREATMENT OUTCOME;

AGE FACTORS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; BLOOD PRESSURE; DIURETICS; DRUG THERAPY, COMBINATION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; SPAIN; TETRAZOLES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036435890     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.62.s82.8.x     Document Type: Article

References (30)

1. Kannel W, Hjortland MC, McNamara PM, Gordon T: Menopause and risk of cardiovascular disease: The Framingham study. Ann Intern Med 875:447-452, 1976
2. National Center for Health Statistics: Mortality, Part A, in Vital Statistics of the United States. 1992 (vol 11), Hyattsville, US Dept of Health and Human Services, Public Health Services, 1996, DHHS publication 96-1101
3. Rees LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK (eds). SEER Cancer Statistics Review 1973-1993, Bethesda, MD, 1997
4. Staessen J, Bulpitt CJ, Fagard R, et al: The influence of menopause on blood pressure. J. Human Hypertens 3:427-433, 1989
5. Owens JF, Stoney CM, Mathews KA: Menopause status influences ambulatory blood pressure changes during mental stress. Circulation 88:2794-2802, 1993
6. Campese VM: Salt sensitivity in hypertension: Renal and cardiovascular implications. Hypertension 23:531-550, 1994
7. Mendelshon ME, Karas RH: Estrogens and the blood vessel wall. Curr Op Cardiol 9:619-626, 1994
8. Karas RH, Patterson BL, Mendelshon ME: Human vascular smooth muscle cells contain functional estrogen receptors. Circulation 89:1943-1950, 1994
9. Clavell AL, Burnett JC: Physiologic and pathophysiologic roles of endothelin in the kidney. Curr Oper Nephrol Hypertens 3:66-72, 1994
10. Schunkert H, Jan Danser AH, Hense HW, et al: Effects of estrogen replacement therapy on the renin-angiotensin system in post-menopausal women. Circulation 95:39-45, 1997
11. Joint National Committee on Prevention: Detection, evaluation and treatment of high blood pressure, The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157:2413-2446, 1997
12. World Health Organization: International Society of Hypertension. 1999 WHO-ISH Guidelines for the management of hypertension. J Hypertens 17:151-183, 1999
13. Bush T: The epidemiology of cardiovascular disease in postmenopausal women. Ann N Y Acad Sci 592:263-271, 1990
14. Amigoni S, Morelli P, Parazzini F, Chatenoud L: Determinants of elevated blood pressure in women around menopause: Results from a cross-sectional study in Italy. Maturitas 34:25-32, 2000
15. Wassertheil-Smoller S, Anderson G, Psaty BM, et al: Hypertension and its treatment in postmenopausal women: Baseline data from the Women's Health Initiative. Hypertension 36:780-789, 2000
16. The Menopausal Estrogen/Progestin Intervention Trial (PEPI): Effects of estrogen/progesteron regimens on heart disease risk factors in postmenopausal women. JAMA 273:199-208, 1995
17. Lip GYH, Beevers M, Churchill D, Beevers DG: Hormone replacement therapy and blood pressure in hypertensive women. J Hum Hypertens 8:491-494, 1994
18. Hasseger C, Riis BJ, Strom V, et al: The long-term effects of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation 76:753-758,1987
19. Hassager C, Christiansen C: Blood pressure during estrogen/progestan substitution therapy in the healthy post menopausal women. Maturitas 9:315-323, 1988
20. Loutola H: Blood pressure and hemodynamics in postmenopausal women during estradiol-17 beta substitution. Am Clin Res 15:112-121, 1983
21. Brylance TA, Brincat M, Lafferty K, et al: Natural progesteron and antihypertensive action. BMJ 290:13-14, 1985
22. Hamlet MA, Rorie DK, Tyce GM: Effects of estradiol on release and disposition of norepinephrine from nerve endings. Am J Physiol 239:450-456, 1980
23. Wren BG, Rotledge AD: The effect of type and dose of oestrogen on the blood pressure of post-menopausal women. Maturitas 5:135-142, 1983
24. Maschkak CA, Lobo RA: Estrogen replacement therapy and hypertension. J Reprod Med 10(Suppl):805-810, 1985
25. Pfeffer RA, Kurosaki TT, Charlton SK: Estrogen use and blood pressure in later life. Am J Epidemiol 110:469-478, 1979
26. Hammond CB, Jelovsek FR, Lee KL, et al: Effects of long-term estrogen replacement therapy y metabolic effects. Am J Obstet Gynecol 133:525-536, 1979
27. Kornhauser C, Mlacara JM, Garay ME, Pérez-Luque EL: The effect of hormone replacement therapy on blood pressure and cardiovascular risk factors in menopausal women with moderate hypertension. J Hum Hypertens 11:405-411, 1997
28. Seely EW, Walsh BW, Gerhard MD, Williams GH: Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women. Hypertension 33:1190-1194, 1999
29. Conferencia de Consenso de la Asociación Española Para el Estudio de la Menopausia: Criterios de administración de la terapia hormonal sustitutiva, in Conclusiones de la Conferencia de Consenso de la AEEM, edited by A CALAF, Barcelona, 1994
30. Birkhäuser MH: Contraindications today, indications tomorrow, in European Consensus Development Conference on Menopause, edited by Birkhäuser H, Rozembaum H, Montreaux, edit ESKA, 1996, pp 283-282